On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep apnea medication. Zepbound or Tirzepatide is an injectable drug that the company designed as an obesity treatment. READ: Scientists may have found the purpose of sleep The Food and Drug Administration, however, approved it for this
